Novel silica-coated iron-carbon composite particles and their targeting effect as a drug carrier

Journal of Biomedical Materials Research - Part A

Volumn 86, Issue 3, 2008, Pages 671-677

  Cao, Hongming ^a   Gan, Jun ^b   Wang, Shufen ^a   Xuan, Shaofeng ^a   Wu, Qiufang ^a   Li, Chunzhong ^a   Wu, Chuntao ^b   Hu, Chengen ^b   Huang, Guangjian ^b  

^a East China University of Science and Technology   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Doxorubicin; Drug delivery; Magnetic targeting; Radionuclide imaging

Indexed keywords

ADSORPTION; BALL MILLING; CARBON; CHEMOTHERAPY; CIVIL AVIATION; COMPOSITE MATERIALS; DESORPTION; DRUG DELIVERY; DRUG DOSAGE; DRUG THERAPY; GRINDING (MACHINING); HYDROGEN; IRON; MAGNETIC DOMAINS; NONMETALS; SILICA; SILICATE MINERALS; SILICON COMPOUNDS;

CARBON COMPOSITES; COMPOSITE PARTICLES; DOXORUBICIN; DRUG CARRIERS; HIGH ENERGIES; HYDROGEN REDUCTION; IN-VIVO; MAGNETIC TARGETING; PLANETARY BALL MILLING; RADIONUCLIDE IMAGING;

ACTIVATED CARBON;

CARBON; DOXORUBICIN; HYDROGEN; IRON; PERTECHNETIC ACID TC 99M; SILICON DIOXIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DESORPTION; DRUG ADSORPTION; DRUG BLOOD LEVEL; DRUG PENETRATION; DRUG TISSUE LEVEL; INTERSTITIUM; LIVER; LIVER CELL; MAGNETIC FIELD; NONHUMAN; REDUCTION; SWINE;

ADSORPTION; ANIMALS; CARBON; DOXORUBICIN; DRUG CARRIERS; HEPATOCYTES; IRON; NANOPARTICLES; RADIONUCLIDE IMAGING; SILICON DIOXIDE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SWINE; X-RAY DIFFRACTION;

EID: 49149090784     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31647     Document Type: Article

References (21)

1. Mayer LD. Future developments in the selectivity of anticancer agents: Drug delivery and molecular target strategies. Cancer Metastasis Rev 1998;17:211-218.
2. Molema G. Tumor vasculature directed drug targeting: Applying new technologies and knowledge to the development of clinically relevant therapies. Pharm Res 2002;19:1251-1258.
3. Luo Y, Prestwich GD. Cancer-targeted polymeric drugs. Curr Cancer Drug Targets 2002;2:209-226.
4. Hafeli UO. Magnetically modulated therapeutic systems. Int J Pharm 2004;277:19-24.
5. Zhao W, Gu J, Zhang L, Chen H, Shi J. Fabrication of uniform magnetic nanocomposite spheres with a magnetic core/mesoporous silica shell structure. J Am Chem Soc 2005;127:8916-8917.
6. Bourlinos AB, Simopoulos A, Boukos N, Petridis D. Magnetic modification of the external surfaces in the MCM-41 porous silica: Synthesis, characterization, and functionalization. J Phys Chem B 2001;105:7432-7437.
7. Gross AF, Diehl MR, Beverly KC, Richman EK, Tolbert SH. Controlling magnetic coupling between cobalt nanoparticles through nanoscale confinement in hexagonal mesoporous silica. J Phys Chem B 2003;107:5475-5482.
8. Pouliquen D, Chouly C. Magnetic microcarriers for medical applications. In: Arshady R, editor. Microspheres Microcapsules and Liposomes, vol. 2: Medical and Biotechnology Applications. London: Citus; 1999. p 343-382.
9. Lai CY, Trewyn BG, Jeftinija K, Xu S, Jeftinija S, Lin VS. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. J Am Chem Soc 2003;125:4451-4459.
10. Lee MR, Baek KH, Jin HJ, Jung YG, Shin I. Targeted enzyme-responsive drug carriers: Studies on the delivery of a combination of drugs. Angew Chem Int Ed 2004;43:1675-1678.
11. Vallet-Regi M, Ramila A, del Real RP, Perez-Pariente J. A new property of MCM-41: Drug delivery system. Chem Mater 2001;13:308-311.
12. Yoshizawa N, Yamada Y, Furuta T, Shiraishi M, Kojima S, Tamai H, Yasuda H. Coal-based activated carbons prepared with organometallics and their mesoporous structure. Energy Fuels 1997;11:327-330.
13. Tamai H, Kakii T, Hirota Y, Kumamoto T, Yasuda H. Synthesis of extremely large mesoporous activated carbon and its unique adsorption for giant molecules. Chem Mater 1996;8:454-462.
14. Rudge SR, Kurtz TL, Vessely CR. Preparation, characterization and performance of magnetic iron-carbon composite microparticles for chemotherapy. Biomaterials 2000;21:1411-1420.
15. Barbe CB, Bartlett J, Kong L, Finnie K, Lin HQ, Larkin M, Calleja S, Bush A, Calleja G. Silica particles: A novel drug-delivery system. Adv Mater 2004;16:1959-1966.
16. Goodwin S, Peterson C, Hoh C. Targeting and retention of magnetic targeted carriers (MTCs) enhancing intra-arterial chemotherapy. J Magn Magn Mater 1999;194:132-139.
17. Torchilin VP. Drug targeting. Eur J Pharm Sci 2001;11:S81-S91.
18. Chen CC, Liu YC, Wu CH, Yeh CC, Su MT, Wu YC. Preparation of fluorescent silica nanotubes and their application in gene delivery. Adv Mater 2005;17:404-407.
19. Yi DK, Selvan ST, Lee SS, Georgia C. Silica-coated nanocomposites of magnetic nanoparticles and quantum dots. J Am Chem Soc 2005;127:4990-4991.
20. Gu F, Li CZ, Wang SF, Lu MK. Solution-phase synthesis of spherical zinc sulfide nanostructures. Langmuir 2006;22:1329-1332.
21. Ma D, Li M, Patil AJ, Mann PS. Fabrication of protein/silica core-shell nanoparticles by microemulsion-based molecular wrapping. Adv Mater 2004;16:1838-1841.